[1]吴卓霏 周卓宁 谢 斌 左 田.基于肠道菌群探讨疏肝健脾法对DGP的防治[J].大众科技,2021,23(11):83-86.
　Discussion on the Prevention and Treatment of DGP by Soothing Liver and Activating Spleen Method Based on Intestinal Flora[J].Popular Science & Technology,2021,23(11):83-86.
点击复制

基于肠道菌群探讨疏肝健脾法对DGP的防治()
分享到：

《大众科技》[ISSN:1008-1151/CN:45-1235/N]

卷:
23
期数:
2021年11
页码:
83-86
栏目:
医药与卫生
出版日期:
2021-11-20

文章信息/Info

Title:
Discussion on the Prevention and Treatment of DGP by Soothing Liver and Activating Spleen Method Based on Intestinal Flora
作者:
吴卓霏1 周卓宁2 谢 斌1 左 田1　
（1.广西中医药大学，广西 南宁 530000；2.广西中医药大学附属瑞康医院，广西 南宁 530011）
关键词:
肠道菌群; 疏肝健脾法; 糖尿病胃轻瘫
Keywords:
intestinal flora soothing liver and activating spleen method diabetic gastroparesis
文献标志码:
A
摘要:
糖尿病胃轻瘫（diabetic gastroparesis，DGP）的发生发展与肠道菌群密切相关，肠道菌群可以通过影响血糖及炎症因子导致糖尿病胃轻瘫。疏肝健脾法是临床上治疗该病常用的方法，笔者认为疏肝解郁法可能通过调节肠道菌群起到治疗作用，故探讨疏肝健脾法、肠道菌群、糖尿病胃轻瘫三者的相关性，分析三者可能存在的联系，为疏肝健脾类中药在临床上治疗本病起效机制提供新的理论依据，充分发挥中医药的优势。
Abstract:
The occurrence and development of diabetic gastroparesis (DGP) is closely related to the intestinal flora, which can cause DGP by affecting blood glucose and inflammatory factors. Soothing liver and activating spleen method is commonly used in clinical treatment of this disease. The author thinks that soothing liver and activating spleen method may play a therapeutic role by regulating intestinal flora. Therefore, this paper discusses the correlation among soothing liver and activating spleen method, intestinal flora and DGP, and analyzes the possible relationship among them, so as to provide a new theoretical basis for the mechanism of soothing liver and activating spleen traditional Chinese medicine in clinical treatment of this disease, giving full play to the advantages of traditional Chinese medicine.

参考文献/References:

[1] Sullivan A, Temperley L, Ruban A. Pathophysiology, aetiology and treatment of gstroparesis[J]. Digestive Diseases and Sciences, 2020, 65(6): 1615-1631. [2] Farmer A D, Bruckner-Holt C, Schwartz S, et al. Diabetic gastroparesis: perspectives from a patient and health care providers[J]. Journal of Patient-Centered Research and Reviews, 2019, 6(2): 148-157. [3] 阮婷婷. 疏郁健脾汤治疗肝郁脾虚型糖尿病胃轻瘫的临床研究[D]. 太原: 山西中医药大学，2020. [4] Lupien-Meilleur J, Andrich D E, Quinn S, et al. Interplay between gut microbiota and gastrointestinal peptides: potential outcomes on the regulation of glucose control[J]. Canadian Journal of Diabetes, 2020, 44(4): 359-367. [5] 贾冰. 疏肝健脾法治疗肠易激综合征的研究及对肠道菌群的影响[D]. 昆明: 云南中医学院，2017. [6] Kalam A M A, Manobendro S, Tiejun L, et al. Probiotic species in the modulation of gut microbiota: an overview[J]. BioMed Research International, 2018, 2018: 9478630. [7] Tams H, Ilona S. Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome[J]. Orvosi Hetilap, 2016, 157(1): 13-22. [8] Lambeth S M, Carson T, Lowe J, et al. Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes[J]. Journal of Diabetes and Obesity, 2015, 2(3): 1-7. [9] 赵先群，张雪松，刘晓政，等. 糖尿病胃轻瘫患者肠道菌群分布及炎症因子水平变化的观察[J]. 中国糖尿病杂志，2017，25(8): 725-728. [10] Ku?ik E, Dudkowiak R, Adamiec R, et al. Diabetic autonomic neuropathy of the gastrointestinal tract[J]. Przeglad Gastroenterologiczny, 2020, 15(2): 89-93. [11] Priyadarshini M, Kotlo K U, Dudeja P K, et al. Role of short chain fatty acid receptors in intestinal physiology and pathophysiology[J]. Comprehensive Physiology, 2018, 8(3): 1091-1115. [12] Wahlstr? A, Sayin S I, Marschall S U, et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism[J]. Cell Metabolism, 2016, 24(1): 41-50. [13] Zhao L, Lou H, Peng Y, et al. Elevated levels of circulating short-chain fatty acids and bile acids in type 2 diabetes are linked to gut barrier disruption and disordered gut microbiota[J]. Diabetes Research and Clinical Practice, 2020, 169(6): 108418. [14] Ge X, Pan J, Liu Y, et al. Intestinal crosstalk between microbiota and serotonin and its impact on gut motility[J]. Current Pharmaceutical Biotechnology, 2018, 19(3): 190-195. [15] Salazar J, Davila L C A, Morillo V, et al. Microbiota and diabetes mellitus: role of lipid mediators[J]. Nutrients, 2020, 12(10): 3039. [16] Zhao X, Wang H, Zhang Z, et al. Effects of ethyl acetate extract of Salsola collina on brain-gut peptides and interstitial cells of g astric Cajal in rats with diabetic gastroparesis[J]. Iranian Journal of Basic Medical Sciences, 2020, 23(9): 1218-1224. [17] Hu X, Liu J, Sun L, et al. TAp63 is correlated with chronic inflammation in patients with newly diagnosed type 2 diabetes mellitus[J]. Journal of Diabetes and Its Complications, 2018, 32(3): 335-341. [18] 黄举凯，程淑莉，关婷婷，等. 糖尿病胃轻瘫的中医治疗思路初探[J]. 中华中医药杂志, 2020, 35(1): 304-306. [19] 张懿，袁群，杨一文，等. 加味四君子汤对糖尿病胃轻瘫患者的临床疗效及胃蛋白酶原的影响研究[J]. 中药材, 2019, 42(9): 2185-2188. [20] 屈璐，侯胜开，管志敏，等. 疏肝和胃汤治疗肝胃不和型糖尿病胃轻瘫28例[J]. 中医药导报，2017, 23(3): 99-100，3. [21] 韩笑，朴春丽，李昕萌. 健脾疏肝方联合针刺治疗糖尿病胃轻瘫(肝郁脾虚证)的临床研究[J]. 辽宁中医杂志，2017, 44(10): 2129-2131. [22] 杨旭，岳仁宋，徐萌，等. 探讨糖尿病胃轻瘫大鼠肠道菌群失衡致免疫功能失调的机制研究及半夏泻心汤的干预作用[J]. 中药药理与临床，2019，35(2): 17-21. [23] Chen Y, Bai J, Wu, D et al. Association between fecal microbiota and generalized anxiety disorder: severity and early treatment response[J]. Journal of Affective Disorders 2019, 259: 56-66. [24]Li?iewicz P, Kaczmarczyk M, Misiak B, et al. Analysis of gut microbiota and intestinal integrity markers of inpatients with major depressive disorder[J]. Progress in Neuropsychopharmacology and Biological Psychiatry, 2021, 106: 110076. [25] Zheng P, Zeng B, Zhou C, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the hosts metabolism[J]. Journal of Molecular Psychiatry, 2016, 21(6): 786-796. [26] Rao J, Xie R, Lin L, et al. Fecal microbiota transplantation ameliorates gut microbiota imbalance and intestinal barrier damage in rats with stress-induced depressive-like behavior[J]. European Journal of Neuroscience, 2021, 53(1): 15192. [27] Zhu X, Sun Y, Zhang C, et al. Effects of berberine on a rat model of chronic stress and depressionvia gastrointestinal tract pathology and gastrointestinal flora profile assays[J]. Molecular Medicine Reports, 2017, 15(5): 3161-3171. [28] 马艺鑫，宁顺宇，吕晓明，等. 基于“肝脾相关”理论探讨疏肝健脾法调控肠道微生态防治糖脂代谢性疾病[J]. 时珍国医国药，2020，31(10): 2450-2452. [29] Li P, Wu M, Xiong W, et al. Saikosaponin-d ameliorates dextran sulfate sodium-induced colitis by suppressing NF-κB activation and modulating the gut microbiota in mice[J]. International Immunopharmacology, 2020, 81: 106288. [30] Wang J-H, Bose S, Kim H G, et al. Fermented rhizoma atractylodis macrocephalae alleviates high fat diet-induced obesity in association with regulation of intestinal permeability and microbiota in rats[J]. Scientific Reports, 2015, 5: 8391. [31] 吴佳佳. 逍遥散对肠道菌群失调小鼠神经炎症及结肠上皮屏障的保护作用[D]. 北京: 北京中医药大学，2020. [32] 张鹏横. 从木郁克土探讨围绝经期肝郁证大鼠胃肠功能紊乱的机制[D]. 福州: 福建中医药大学，2020. [33] Zhao J, Li Y, Sun M, et al. The Chinese herbal formula Shenzhu Tiaopi granule results in metabolic improvement in type 2 diabetic rats by modulating the gut microbiota[J]. Evidence-Based Complementary and Alternative Medicine, 2019, 2019: 6976394.

相似文献/References:

[1]吴曼婷,唐红珍.浅谈肠道菌群与肥胖[J].大众科技,2019,21(12):50.
　A Brief Discussion on Intestinal Flora and Obesity[J].Popular Science & Technology,2019,21(11):50.
[2]李 幸,陆石俊,刘雪冰,等.疏肝健脾法在非酒精性脂肪肝中的应用概况[J].大众科技,2019,21(12):72.
　The Application of Liver-Soothing and Spleen-Strengthening Method inNon-Alcoholic Fatty Liver Disease[J].Popular Science & Technology,2019,21(11):72.
[3]黄业保 刘春强.调节肠道菌群治疗功能性便秘的研究进展[J].大众科技,2018,20(10):42.
　Research Progress of the Treatment of Functional Constipation by Regulating Intestinal Flora[J].Popular Science & Technology,2018,20(11):42.
[4]陆　露　黄小珊　韦　飞　匡　朋　傅为武　李成林.基于肠道菌群探讨以脾论治心力衰竭[J].大众科技,2020,22(12):70.
　Discussion on Treating Heart Failure with Spleen Based on Intestinal Flora[J].Popular Science & Technology,2020,22(11):70.
[5]邹　俊　劳晓洁　赵　蕊　梁振国　陈茂伟.HIV/AIDS患者肠道菌群变化研究[J].大众科技,2021,23(1):44.
　Study on Changes of Intestinal Flora in HIV/AIDS Patients[J].Popular Science & Technology,2021,23(11):44.
[6]许阳慧 唐梅文 覃 瑶 姚佳敏 夏琳超.乌梅丸通过调节肠道菌群治疗腹泻型肠易激综合征的研究进展[J].大众科技,2021,23(5):48.
　Research Progress of Wumei Pill in the Treatment of Diarrhea-Type Irritable Bowel Syndrome by Regulating Intestinal Flora[J].Popular Science & Technology,2021,23(11):48.
[7]吴丽萍 陈晓锋 王清碧 金 欣 邵天祥.基于肠道菌群探讨腹针治疗脑卒中后失眠的应用[J].大众科技,2023,25(3):118.
　Discussion on the Application of Abdominal Acupuncture in the Treatment of Insomnia after Stroke Based on Intestinal Flora[J].Popular Science & Technology,2023,25(11):118.

备注/Memo

备注/Memo:
【收稿日期】2021-09-27 【基金项目】广西壮族自治区卫生和计划生育委员会自筹经费科研项目（Z2014559）；广西医疗卫生适宜技术研究与开发项目（S201419-07）。 【作者简介】吴卓霏（1994－），女，广西中医药大学在读硕士研究生，研究方向为内分泌代谢性疾病的临床治疗研究。 【通信作者】周卓宁（1968－），女，广西中医药大学附属瑞康医院主任医师，硕士研究生导师，研究方向为内分泌代谢性疾病的临床治疗研究。
更新日期/Last Update: 2022-02-14